Lymphoma

What did the GELTAMO trial assess in DLBCL ?
Treatment intensification after 3 cycles of R-Mega-CHOP with FDG-avid PET randomized to further R-Mega-CHOP (complete response) or R-IFE then BEAM -Auto-HSCT (persistent disease)

en_USEnglish